Biosergen AB (publ) (STO:BIOSGN)

Sweden flag Sweden · Delayed Price · Currency is SEK
38.40
0.00 (0.00%)
Mar 4, 2026, 9:34 AM CET
Market Cap90.17M -4.7%
Revenue (ttm)n/a
Net Income-40.82M
EPS-17.38
Shares Out2.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume626
Average Volume1,551
Open38.00
Previous Close38.40
Day's Range38.00 - 38.40
52-Week Range28.10 - 67.80
Beta0.32
RSI38.30
Earnings DateMay 6, 2026

About Biosergen AB

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1
Stock Exchange Nasdaq Stockholm
Ticker Symbol BIOSGN
Full Company Profile

Financial Performance

Financial Statements